Backlash over the dramatically increased price of allergy drug EpiPen pushed the drug's manufacturer, Mylan, to announce Thursday that it would cut patient costs. The company plans to offer a savings card for patients with higher out-of-pocket costs, which, Reuters reported, will cover "up to $300" for a two-pack of epinephrine dispensers and cut costs for a patient paying list price by about 50 percent. Mylan will also double eligibility for its existing patient assistance program, which benefits those who are uninsured and under-insured.
"We recognize the significant burden on patients from continued, rising insurance premiums and being forced increasingly to pay the full list price for medicines at the pharmacy counter," Mylan CEO Heather Bresch said in a statement. "Patients deserve increased price transparency and affordable care, particularly as the system shifts significant costs to them."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Why more and more adults are reaching for soft toysUnder The Radar Does the popularity of the Squishmallow show Gen Z are 'scared to grow up'?
-
Magazine solutions - December 27, 2024 / January 3, 2025Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
-
Magazine printables - December 27, 2024 / January 3, 2025Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
-
Judges block $25B Kroger-Albertsons mergerSpeed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
-
Rupert Murdoch loses 'Succession' court battleSpeed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
-
Bitcoin surges above $100k in post-election rallySpeed Read Investors are betting that the incoming Trump administration will embrace crypto
-
Enron mystery: 'sick joke' or serious revival?Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
-
US charges Indian tycoon with bribery, fraudSpeed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
-
Boeing machinists approve contract, end strikeSpeed Read The company's largest union approved the new contract offer, ending a seven-week strike
-
US economy still strong in final preelection reportSpeed Read It grew at a solid 2.8% annual rate from July through September
-
Boeing machinists reject deal, continue strikeSpeed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
